24 results
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
with respect to such amendment or re-enactment; (g) words denoting the singular shall include the plural and vice versa and words denoting any gender shall
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
Not Disclose Gender
Part I: Gender Identity
Directors
Part II: Demographic Background
Underrepresented Individual in Home Country Jurisdiction
LGBTQ+
Did
6-K
EX-1
AUTL
Autolus Therapeutics plc
1 Jul 22
Current report (foreign)
5:15pm
of personal characteristics such as race, disability, gender, sexual orientation, religion or age.
A breakdown of the employment statistics as of 31
F-6EF
EX-99
crr4p5wo 3b0ajir
9 Nov 21
Automatic registration for ADRs (foreign)
4:02pm
6-K
EX-99.3
ivbna
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-1
wbbw boen95dqqgv
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-99.3
kex7bceokb zspft
7 Dec 20
Updated data from the ALLCAR study suggests AUTO1’s potential for transformational activity in adult patients with r/r ALL
4:00pm
6-K
EX-1
rb8psq3n1fsi
26 May 20
Current report (foreign)
4:31pm
6-K
EX-1
sipl1z kkgghh
15 Mar 19
Annual Report and Accounts
5:26pm
S-8
EX-4.2
fv85jsouvrvk8
31 Jul 18
Registration of securities for employees
4:09pm
S-8
EX-99.1
43hicbt1p3ks0
31 Jul 18
Registration of securities for employees
4:09pm
S-8
EX-4.1
pts wzmqmpbwc
31 Jul 18
Registration of securities for employees
4:09pm
F-6/A
EX-99
bkc477wg505kcoy
19 Jun 18
Registration for ADRs (foreign) (amended)
4:10pm
F-1/A
EX-3.1
twcpkgilkrfg9 3b
19 Jun 18
Registration statement (foreign) (amended)
8:05am
F-6/A
EX-99
rt7jczwo m7ieba9y5
19 Jun 18
Registration for ADRs (foreign) (amended)
12:00am
F-1/A
EX-3.1
u0m31kp
8 Jun 18
Registration statement (foreign) (amended)
6:25am